Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
9.86
+0.12 (1.23%)
At close: Aug 29, 2025, 4:00 PM
9.85
-0.01 (-0.10%)
After-hours: Aug 29, 2025, 4:09 PM EDT

Exagen Statistics

Total Valuation

Exagen has a market cap or net worth of $216.96 million. The enterprise value is $212.22 million.

Market Cap216.96M
Enterprise Value 212.22M

Important Dates

The last earnings date was Tuesday, July 29, 2025, before market open.

Earnings Date Jul 29, 2025
Ex-Dividend Date n/a

Share Statistics

Exagen has 22.00 million shares outstanding. The number of shares has increased by 6.55% in one year.

Current Share Class 22.00M
Shares Outstanding 22.00M
Shares Change (YoY) +6.55%
Shares Change (QoQ) +13.62%
Owned by Insiders (%) 4.46%
Owned by Institutions (%) 37.50%
Float 14.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.20
Forward PS 2.98
PB Ratio 10.31
P/TBV Ratio 10.31
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.61
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.95, with a Debt / Equity ratio of 1.20.

Current Ratio 4.95
Quick Ratio 4.30
Debt / Equity 1.20
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.03

Financial Efficiency

Return on equity (ROE) is -87.94% and return on invested capital (ROIC) is -19.94%.

Return on Equity (ROE) -87.94%
Return on Assets (ROA) -16.24%
Return on Invested Capital (ROIC) -19.94%
Return on Capital Employed (ROCE) -28.97%
Revenue Per Employee $273,777
Profits Per Employee -$78,977
Employee Count215
Asset Turnover 1.09
Inventory Turnover 7.22

Taxes

In the past 12 months, Exagen has paid $49,000 in taxes.

Income Tax 49,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +241.18% in the last 52 weeks. The beta is 1.62, so Exagen's price volatility has been higher than the market average.

Beta (5Y) 1.62
52-Week Price Change +241.18%
50-Day Moving Average 8.15
200-Day Moving Average 5.57
Relative Strength Index (RSI) 65.41
Average Volume (20 Days) 226,311

Short Selling Information

The latest short interest is 551,616, so 2.51% of the outstanding shares have been sold short.

Short Interest 551,616
Short Previous Month 1.41M
Short % of Shares Out 2.51%
Short % of Float 3.84%
Short Ratio (days to cover) 1.45

Income Statement

In the last 12 months, Exagen had revenue of $58.86 million and -$16.98 million in losses. Loss per share was -$0.89.

Revenue58.86M
Gross Profit 34.98M
Operating Income -14.04M
Pretax Income -17.28M
Net Income -16.98M
EBITDA -12.30M
EBIT -14.04M
Loss Per Share -$0.89
Full Income Statement

Balance Sheet

The company has $30.03 million in cash and $25.30 million in debt, giving a net cash position of $4.74 million or $0.22 per share.

Cash & Cash Equivalents 30.03M
Total Debt 25.30M
Net Cash 4.74M
Net Cash Per Share $0.22
Equity (Book Value) 21.03M
Book Value Per Share 0.96
Working Capital 40.69M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.37 million and capital expenditures -$615,000, giving a free cash flow of -$15.98 million.

Operating Cash Flow -15.37M
Capital Expenditures -615,000
Free Cash Flow -15.98M
FCF Per Share -$0.73
Full Cash Flow Statement

Margins

Gross margin is 59.42%, with operating and profit margins of -23.85% and -28.85%.

Gross Margin 59.42%
Operating Margin -23.85%
Pretax Margin -28.76%
Profit Margin -28.85%
EBITDA Margin -20.89%
EBIT Margin -23.85%
FCF Margin n/a

Dividends & Yields

Exagen does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.55%
Shareholder Yield -6.55%
Earnings Yield -7.83%
FCF Yield -7.37%

Analyst Forecast

The average price target for Exagen is $11.75, which is 19.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target $11.75
Price Target Difference 19.17%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 13.44%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Exagen has an Altman Z-Score of -4.98 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.98
Piotroski F-Score 4